Reshma Rangwala

EVP & Chief Medical Officer, Karyopharm Therapeutics Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.1M

Companies

Latest trade

May 14, 2026

Companies

Karyopharm Therapeutics Inc.EVP & Chief Medical Officer −$0.1M

Trades

KPTI Sold 408 shares at $9.50 $0.0M May 14

KPTI Sold 449 shares at $8.94 $0.0M Apr 21

KPTI Sold 5,066 shares at $9.41 $0.0M Mar 2

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.